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SUMMARY 
Acanthamoeba are opportunistic protozoan parasites that can cause painful, vision-
threatening keratitis. However the pathogenesis and pathophysiology of 
Acanthamoeba keratitis remain incompletely understood. Most cases of 
Acanthamoeba keratitis develop as a result of poor hygiene in contact lens care but it 
is unclear how amoebae transmigrate from the environment into the cornea leading to 
inflammation, photophobia and blindness. Acanthamoeba keratitis has become 
increasingly important in the past few decades due to increasing populations of 
contact lens users. The mechanisms associated with the pathogenesis of 
Acanthamoeba are highly complex, depending on the virulence properties of the 
parasite, host susceptibility and the environmental conditions. Complete 
understanding of Acanthamoeba pathogenesis and its associated risks factors should 
allow us to design strategies for disease prevention and for the rational development 
of therapeutic interventions against these devastating infections.  
               
               Acanthamoeba keratitis has become a significant problem in recent years,  
                especially in contact lens wearers exposed to contaminated water. 
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INTRODUCTION  
Genus Acanthamoeba is a group of 
free-living protozoan that are widely 
distributed in the environment. For 
example, Acanthamoeba have been 
isolated from air, soil, freshwater, 
seawater, tap water, bottled mineral 
water, laboratory distilled water wash 
bottles, chlorinated swimming pools, 
sewage, food materials and considered 
as one of the most ubiquitous 
organisms (Khan and Paget, 2002; De 
Jonckheere, 1991; Kilvington and 
White, 1994; Ma et al., 1990). This is 
further supported with recent findings 
that more than 80% individuals contain 
serum antibodies against 
Acanthamoeba antigens (Chappell et 
al., 2001). The ubiquity of 
Acanthamoeba is a major contributing 
factor in Acanthamoeba infections as it 
provides them with a greater access to 
the susceptible hosts. Acanthamoeba 
are able to withstand these diverse 
environmental conditions by switching 
their phenotype. Under harsh 
environmental conditions such as 
deprivation of food, high temperature 
and high osmolarity, Acanthamoeba 
transform into a resistant cyst form, 
which is metabolically inactive and 
presents a major problem in therapy 
(Fig. 1). The reverse conditions would 
lead to the emergence of vegetative 
trophozoite form. Acanthamoeba 
trophozoite divide by binary fission 
and given the opportunity can cause 
serious human infections (Byers, 1979; 
Byers et al., 1991; Ma et al., 1990).  
 
Genus Acanthamoeba consists of both 
virulent and avirulent strains. Recent 
advances in molecular techniques have 
lead to the classification of this genus 
into 13 different genotypes using 
rDNA sequence analyses i.e., T1 – T12 
and T14 (Stothard et al., 1998; Gast, 
2001). The basis of this scheme is that 
each genotype exhibits at least 6% 
sequence difference from all the other 
 
Figure 1. The life cycle of Acanthamoeba 
castellanii. A) Infective form of A. 
castellanii, also known as trophozoites, as 
observed under scanning electron 
microscope and B) under phase-contrast 
microscope. Under unfavorable 
conditions, trophozoites differentiate into 
cysts. C) Cysts form of A. castellanii, 
characterized by double wall as indicated 
by arrows. Bar = 5 µm (reprinted with 
permission from Microbial Pathogenesis).  
 
genotypes (Gast et al., 1996). 
However, sequence analyses of all 
keratitis isolates tested to date, 
revealed that keratitis-causing isolates 
belong to the genotypes, T3, T4, T6 
and T11 (Stothard et al., 1998; Khan et 
al., 2002a; Walochnik et al., 2000; 
Walochnik et al., 2000a). Furthermore, 
it is shown that more than 95% 
Acanthamoeba isolates that produce 
keratitis belong to T4 genotype, 
suggesting that pathogenicity may be 
limited to a certain closely related 
genotypes (Stothard et al., 1998; Khan 
et al., 2002a; Walochnik et al., 2000). 
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For example, Booton et al., (2002), 
tested 13 Acanthamoeba, isolated from 
clinical samples, contact lenses, lens 
cases or lens case solutions in Hong 
Kong. The results revealed that 12 
belong to T4 genotype and one T3 
isolate. Again, in a recent study, De 
Jonckheere (2003), has determined T4 
as the sole keratitis-producing 
genotype in all nine Acanthamoeba 
keratitis cases in Belgium. Although 
the rDNA sequence information of an 
organism is not a measure of isolate’s 
pathogenicity, the above findings 
conclusively indicate that sequence 
information can be used to indicate the 
pathogenic potential of a given isolate, 
which should be further verified using 
in vitro and in vivo models. Overall, 
these studies have shown that T4 is the 
major keratitis-producing genotype. 
However, whether predominance of T4 
isolates in keratitis is due to greater 
virulence or greater prevalence 
remains to be determined.    
 
 
Figure 2. Acanthamoeba infected eye 
exhibiting the severity of the disease. 
Note the ulcerated epithelium and 
stromal infiltration exhibiting corneal 
opacity in acute Acanthamoeba 
keratitis (reprinted with permission 
from Microbial Pathogenesis).  
 
Given access and the susceptible hosts, 
pathogenic Acanthamoeba can cause 
blinding keratitis (Fig. 2). 
Acanthamoeba keratitis is initiated by 
direct exposure of the eyes to 
contaminated water and more 
frequently with poor hygiene in the 
contact lens use. The latter is 
facilitated with washing contact lenses 
in tap water, home-made saline as well 
as contact lens wear during swimming. 
Contact lens wear for extended periods 
of time and chlorine-based cleaning 
solutions are additional risk factors 
associated with Acanthamoeba 
keratitis. Acanthamoeba keratitis is 
characterized by severe pain due to 
radial neuritis and inflammation with 
redness and photophobia. If not 
diagnosed early and treated 
aggressively, the corneal epithelium 
becomes ulcerated with stromal 
infiltration (Fig. 2) leading to 
perforation, ring infiltrate and, finally, 
loss of vision. To date, there have been 
more than 1350 estimated cases of 
Acanthamoeba keratitis reported 
worldwide with a continuous rise due 
to an increasing population of contact 
lens wearers (Martinez, 2001). Other 
infections due to Acanthamoeba 
include granulomatous amoebic 
encephalitis (GAE) that often results in 
death. GAE is thought to be initiated 
by entry of amoebae through lower 
respiratory tract or skin lesions, 
followed by hematogenous spread. 
Although not proven clinically, it is 
likely that circulating amoebae cross 
the blood-brain barrier to gain entry 
into the central nervous system (CNS) 
to produce disease. GAE is 
characterized by subacute or chronic 
granulomatous encephalitis with 
clinical features such as, stiff neck, 
headache, fever, nausea and seizures. 
These conditions could last for several 
months, and mostly affect 
immunocompromised patients (Ma et 
al., 1990).  
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Table 1. Risk factors associated with Acanthamoeba keratitis 
 
No. Risk factors 
1 Handling of contact lenses (CL) with unclean hands  
2 Washing CL with home-made saline / tap water 
3 CL wear for more than recommended times  
4 CL wear during swimming 
5 Washing eye/swimming with corneal trauma – splashing eyes with 
contaminated water 
6 Reusing CL without proper cleaning 
7 Incubating CL in disinfectants for less than recommended times 
8 Chlorine-based disinfectants are less effective in killing Acanthamoeba 
Recommendations –  
Combination of disinfectants, which can prevent biofilm formation in contact-lens 
storage case and effectively kill Acanthamoeba 
Improving personal hygiene and dealing with eye with gentle care 
 
Despite the increasing importance of 
Acanthamoeba infections and their 
devastating consequences, the precise 
mechanisms associated with the   
pathogenesis of Acanthamoeba remain 
unclear. Understanding the molecular 
basis of Acanthamoeba pathogenicity 
is crucial for the development of 
therapeutic interventions. It is well-
established that pathogenicity is a 
complex process that involves multiple 
factors, both from the parasite side and 
the host side, and there is no single 
determinant that causes or permits 
these parasites to produce human 
diseases. This review describes some 
of the determinants, which directly or 
indirectly contribute to Acanthamoeba 
keratitis and may also prove relevant in 
GAE. This by no means should be 
considered as a complete list, and 
undoubtedly, further research will 
continue to identify factors responsible 
for Acanthamoeba pathogenesis. 
 
A)  Direct virulence factors  
1.  Contact-dependent mechanisms 
1a.  Adhesion 
Adherence is an important microbial 
property required for colonization, 
persistence and a key step in the 
infection. Thus anti-adhesion therapies  
 
provide attractive approaches to 
prevent many infectious diseases. 
Adhesion in Acanthamoeba is known 
to be a prerequisite in its pathogenesis 
and is mediated by an adhesin-receptor 
fashion. Acanthamoeba uses adhesion 
to host cells both as an initial step 
before proceeding to the deeper tissue 
to produce keratitis as well as to avoid 
being washed out during the onset of 
the disease. It is well-recognized that 
binding of pathogenic Acanthamoeba 
to corneal epithelial cells is mediated 
by amoeba lectin i.e., a 130 KD 
subunit of ~400 KD oligomer 
(composed of at least three 130 KD 
subunits). MBP (∼833aa) consists of a 
N-terminus domain (residues 1-21 that 
codes for cleavable signal peptide), a 
large extracellular domain, a 
transmembrane region and a C-
terminus cytoplasmic domain. The 
extracellular domain contains five 
putative N-glycosylation sites and 
three O-glycosylation sites (Garate et 
al., 2004). Adhesion of Acanthamoeba 
to host cells can be inhibited in the 
presence of exogenous α-mannose 
(Morton et al., 1991; Yang et al., 
1997). Recent studies have shown that 
mannose-binding protein mediates 
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Acanthamoeba binding to human brain 
microvascular endothelial cells, which 
may lead to the transmigration of 
amoebae to the central nervous system 
(Alsam et al., 2003), an important step 
in the development of fatal GAE. 
These findings further indicate that 
mannose-binding protein is an 
important Acanthamoeba adhesin 
responsible for primary interactions 
with the host cells. Similar concepts 
have been established in other 
protozoan parasites such as Entamoeba 
histolytica, which is known to bind and 
lyse the host cells using its galactose-
binding protein (reviewed in McCoy et 
al., 1994). Moreover, E. histolytica-
produced cytotoxicity on host cells is 
abolished in the presence of exogenous 
galactose suggesting that it is a 
contact-dependent mechanism. In an 
attempt to determine the role of 
binding in the pathogenesis of 
Acanthamoeba, cytotoxicity assays 
were performed in the presence of 
exogenous α-mannose, however 
results are somewhat controversial. 
Using in vitro assays, Cao et al., 
(1998), showed that inhibition of 
amoeba binding to corneal epithelial 
cells using exogenous mannose 
resulted in the loss of the ability of 
Acanthamoeba to produce cytotoxicity 
on corneal epithelial cells. In contrast, 
Leher et al., (1998) showed that 
addition of exogenous mannose 
exacerbated the ability of 
Acanthamoeba to produce cytotoxicity 
on corneal epithelial cells. In support 
of this, it was further shown that 
binding of Acanthamoeba to mannose 
residues resulted in increased secretion 
of serine proteases, which are major 
determinants in the host cell damage 
(Leher et al., 1998; Khan et al., 
unpublished data). These studies have 
indicated that Acanthamoeba binding 
to host cells is mediated by mannose-
binding protein, however, binding 
leads to multiple secondary processes 
such as phagocytosis (Khan, 2001), 
and secretion of proteases (Cao et al., 
1998; Leher et al., 1998; Hurt et al., 
2003), which may play a direct role in 
the pathology of the disease. However, 
inhibiting one process, such as binding 
using α-mannose, leads to increase in 
protease secretion that leads to direct 
cellular and tissue damage. These 
findings suggest that engagement of 
mannose-binding protein leads to 
intracellular signal transduction 
pathways, which stimulate the 
secretion of protease(s). At present, it 
is unclear whether mannose-binding 
protein-mediated protease secretion 
involves transcription and translation 
of protease(s) or simply regulated at 
the secretory level. Ideally, inhibition 
of binding without the correct 
engagement of the mannose-binding 
protein may help us understand the role 
of binding in Acanthamoeba 
pathogenesis as well as its use in the 
development of therapeutic 
interventions. For example, it is shown 
that anti-Acanthamoebic IgA 
antibodies inhibit their binding to host 
cells as well as block the secretion of 
cytotoxic substances and play a crucial 
role in the ultimate macrophage-
mediated complement lysis and 
provide protection against 
Acanthamoeba keratitis in vivo model 
(Ferrante 1991; Cursons et al., 1980; 
Leher et al., 1999). However, reports 
are beginning to emerge indicating that 
pathogenic Acanthamoeba can resist 
macrophage-mediated complement 
lysis (Toney and Marciano-Cabral 
1998). In support, Walochnik et al., 
(2001) have shown that pathogenic 
Acanthamoeba bind C1q, component 
of complement pathway, which under 
normal conditions provide basis for 
opsonin and phagocytosis process. 
Additionally, Niederkorn et al., (1999), 
have shown that pathogenic 
Acanthamoeba can degrade IgG and 
IgA antibodies. These studies have 
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suggested that pathogenic 
Acanthamoeba have potential to 
interfere with the immune system, 
which may provide a basis to evade 
host defenses, further indicating the 
need for developing therapeutic 
interventions. 
 
As described above, the genus 
Acanthamoeba has been recently 
classified into 13 different genotypes 
(T1-T12 & T14). In an attempt to 
correlate pathogenicity with a given 
genotype, we tested Acanthamoeba 
isolates belonging to genotypes T1, T2, 
T3, T4, T7 and T11 for their ability to 
bind to corneal epithelial cells and 
brain microvascular endothelial cells. 
We observed that isolates belonging to 
genotypes T1, T3, T4 and T11 
exhibited higher binding to the host 
cells, while T2 isolates, exhibited less. 
Isolates belonging to T7 genotype 
exhibited minimal binding. More 
importantly, differences between T1, 
T3, T4, T11 and T2, T7 isolates, as 
well as, between T2 and T7 were 
significant (P<0.05). Moreover, 
Acanthamoeba isolates, which 
exhibited higher binding, showed 
deleterious host cell cytotoxicity using 
in vitro assays. However, the reason 
for these differences within the genus 
Acanthamoeba and whether these 
differences are genotype-dependent or 
host species-dependent remains 
unclear. Alternatively, it is possible 
that mannose-binding protein is absent 
or antigenically distinct in different 
genotypes of Acanthamoeba 
(previously suggested by Kennett et 
al., 1999). Overall, these data suggest 
that mannose-binding protein is an 
important Acanthamoeba adhesin and 
potential target for future research, 
which will determine its precise role in 
the pathogenesis of Acanthamoeba 
infections in vivo.    
 
 
1b.  Phagocytosis 
As described above, binding of 
Acanthamoeba to host cells stimulate 
secondary processes such as 
phagocytosis. Phagocytosis is a 
process by which Acanthamoeba 
“bites-off” or engulf host cells and 
food particles. Phagocytosis in 
Acanthamoeba has been shown using a 
variety of particles including latex 
beads (Avery et al., 1995; Korn, 1974), 
bacteria (Preston and King, 1984) and 
yeast (Bowers and Olszewski, 1983; 
Allen and Dawidowicz, 1990). 
However, to fully establish the role of 
phagocytosis in the pathogenesis of 
Acanthamoeba keratitis, we have 
recently shown that Acanthamoeba 
phagocytose primary corneal epithelial 
cells (Khan, 2001). We further showed 
that engulfment of corneal epithelial 
cells by Acanthamoeba requires 
cytoskeletal rearrangements and is 
mediated by amoebastomes, present on 
the surface of Acanthamoeba 
suggesting that phagocytosis may play 
a major role in the pathogenesis of 
Acanthamoeba infections (Fig. 3). In 
support, it is shown that actin 
polymerization inhibitor, cytochalasin 
D, blocks Acanthamoeba-mediated 
host cell cytotoxicity (Taylor et al., 
1995). However, specific molecular 
interactions and the underlying 
intracellular signaling pathways 
leading to cytoskeletal rearrangements 
and uptake remain unclear. Similar 
structures have been observed and 
implicated in the pathogenesis of other 
protozoan parasites such as Naegleria 
(John et al., 1985) and Entamoeba 
histolytica (Gonzalez-Robles and 
Martinez-Palomo, 1983; Lushbaugh et 
al., 1978; Martinez-Palomo and 
Martinez-Baez, 1983). Overall, these 
findings suggest that phagocytosis is 
an important virulence property of 
Acanthamoeba, which may play a 
significant role in host cell and tissue 
damage.    
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Figure 3. Acanthamoeba phagocytose 
corneal epithelial cells. Acanthamoeba 
incubated with corneal epithelial cells 
exhibited the presence of amoebastomes 
within 30 minutes of incubation as 
indicated by arrows. These structures are 
known be involved in the phagocytosis of 
Acanthamoeba. A is amoeba, E is corneal 
epithelial cell. (Published with permission 
from Current Microbiology). 
 
The host cell response to 
Acanthamoeba challenge is not clear. 
Recent studies have shown that 
Acanthamoeba induces cell cycle arrest 
in the human corneal epithelial cells 
and human brain microvascular 
endothelial cells. This is shown by 
observations that Acanthamoeba 
inhibits expression of genes including 
cyclins F, G1 and cyclin dependent 
kinase 6 that encode proteins important 
for cell cycle progression and by 
upregulating expression of genes such 
as GADD45A and p130 Rb, associated 
with cell cycle arrest (Sissons et al., 
2004). This is further confirmed at the 
protein level by studying protein 
retinoblastoma (pRb) 
phosphorylations. Retinoblastoma is a 
potent inhibitor of G1/S cell cycle 
progression, however its function is 
inhibited upon phosphorylation, 
allowing progression into the S-phase. 
Our studies revealed that 
Acanthamoeba abolished pRb 
phosphorylations leading to cell cycle 
arrest at G1-to-S transition. Taken 
together, these studies have shown, for 
the first time that Acanthamoeba 
inhibits host cell cycle at the 
transcriptional level as well as by 
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modulating pRb phosphorylations 
using host cell signalling mechanisms 
(Sissons et al., 2004). Other studies 
have shown that Acanthamoeba 
produces host cell DNA fragmentation, 
chromatin condensation and membrane 
blebbing, all well-known markers of 
apoptosis in neuroblastoma cells, 
representing yet another mechanism of 
host cell death (Alizadeh et al. 1994; 
Dove Pettit et al. 1996). However, 
whether cell cycle arrest leading to 
apoptosis and phagocytosis have 
independent roles in the pathogenesis 
of Acanthamoeba infections or 
apoptosis is a primary process, which 
is stimulated by initial binding of 
parasites with the host cells and leads 
to secondary events, such as 
phagocytosis, remains to be 
determined. 
 
Ecto-ATPase activities 
Ecto-ATPases are glycoproteins 
present in the plasma membranes with 
their active sites facing the external 
environment, which suggest that ecto-
ATPases may be involved in surface 
membrane interactions between 
parasites and their host cells. Ecto-
ATPases in protozoa are thought to be 
important for protection from the 
cytolytic effects of ATP, cellular 
adhesion, regulation of ecto-kinase 
substrate concentration, termination of 
purinergic signalling and involvement 
in signal transduction indicating that 
ecto-ATPases may play important roles 
in the pathogenesis of protozoan 
pathogens (Meyer-Fernandes et al., 
1997; Berredo-Pinho et al., 2001; 
Plesner, 1995). Using in vitro assays, it 
is recently shown that Acanthamoeba 
isolates exhibit ecto-ATPase activities 
(Sissons et al., 2004). These findings 
are of particular importance as 
previous studies by Mattana et al., (25) 
demonstrated that ADP release from A. 
castellanii play an important role in its 
contact-independent cytotoxicity, as 
both purified ADP and A. castellanii 
culture supernatant exhibited increased 
levels of intracellular calcium, which 
subsequently leads to apoptosis in 
Wish cells. This is further supported by 
Sissons et al., (2004), who were able to 
inhibit Acanthamoeba-mediated human 
corneal epithelial cell cytotoxicity 
using ecto-ATPase inhibitor, suramin 
(P2 receptor antagonist), clearly 
demonstrating that ecto-ATPases play 
an important role in the pathogenesis 
of Acanthamoeba. In addition, 
exogenous α-mannose significantly 
increased ecto-ATPase activities of 
Acanthamoeba (P<0.05), while other 
sugars had no effect suggesting ecto-
ATPases may well be associated with 
the mannose-binding protein (Sissons 
et al., 2004). This concept is supported 
with the previous findings that 
exogenous galactose stimulate ecto-
ATPase activities of Entamoeba 
histolytica, which posses galactose-
binding protein (Barros et al., 2000). 
These findings together with our 
observations suggest that adhesion 
lectins may be associated with ecto-
ATPase activities. Future studies will 
precisely determine how ecto-ATPases 
are associated with the mannose-
binding protein, which may help us 
identify potential targets to intervene 
these serious infections.      
 
2.  Contact-independent mechanisms 
2a.  Extracellular proteases 
Proteolytic enzymes or proteases are a 
group of enzymes that catalyse the 
degradation of peptide bonds. 
Proteases are major pathogenicity 
determinants in parasitic protozoa, and 
are directly involved in cell and tissue 
invasion and damage. Proteases have 
been implicated in the pathogenesis of 
various protozoan parasites such as 
Entamoeba (Keene et al., 1986; Keene 
et al., 1990), Trichomonas (Arroyo et 
al., 1989), Leishmania (Alfieri et al., 
1989; Bouvier et al., 1987), 
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Trypanosome (Bontempi et al., 1989; 
Kornblatt et al., 1992; Souto-Padron et 
al., 1990), and Plasmodium.(Bernard et 
al., 1987; Chan et al., 1974; Dluzewski 
et al., 1986). A number of studies have 
shown the presence of extracellular 
proteases in pathogenic 
Acanthamoeba. For example, Hadas 
and Mazur (1993), demonstrated the 
presence of a 35 and a 65 KD serine 
proteases from eight species of 
Acanthamoeba. Later studies revealed 
the presence of 43, 59, 70 and 100-130 
KD cysteine proteases and 33, 42, 47, 
60, 75, 100 and 133 KD serine 
proteases in Acanthamoeba (Alfieri et 
al., 2000; Cho et al., 2000; Kong et al., 
2000; Kim et al., 2003; Leher et al., 
1998). Other studies have shown the 
presence of additional 12, 107 and 230 
KD serine proteases (Cao et al., 1998; 
Khan et al., 2000; Na et al., 2001), as 
well as other hydrolytic enzymes such 
as elastase (Ferrante and Bates, 1988), 
phospholipase A (Cursons & Brown, 
1978; Mishra et al., 1985; Victoria & 
Korn, 1975) and there is some 
indication of metalloprotease activities 
in Acanthamoeba (Mitro et al., 1994). 
The diverse nature of results in these 
studies may well be due to their 
complex biology or the differences in 
Acanthamoeba strains. Alternatively, 
parasites grown under various 
conditions using different nutritional 
supplements may exhibit diverse 
protease activities. However, to date, 
there is a common consensus on the 
importance of serine proteases in the 
pathogenesis of Acanthamoeba. This is 
supported by recent findings, which 
showed a direct cytotoxic role of 
extracellular serine proteases in host 
cell cytotoxicity in vivo assays (He et 
al., 1990; Na et al., 2001). It was also 
shown that inhibition of proteases 
using phenylmethylsulfonyl fluoride 
(PMSF, a serine protease inhibitor) 
abolished host cell cytotoxicity of 
corneal epithelial cells clearly 
suggesting that serine proteases play a 
crucial role in the pathogenesis of 
Acanthamoeba keratitis (Leher et al., 
1998). Furthermore, pathogenic 
Acanthamoeba exhibited higher serine 
protease activities as compared to non-
pathogens (Khan et al., 2001). 
Acanthamoeba proteases mediate 
cytotoxicity by affecting host cell 
cytoskeleton and require increase in 
cytosolic free-calcium levels (Mattana 
et al., 1997; Taylor et al., 1995). In 
addition, extracellular proteases of 
Acanthamoeba appear to stimulate 
apoptosis in neuroblastoma cells 
(Alizadeh et al., 1994). Whatever the 
mechanisms of host cell death, the 
precise target(s) of proteases remain 
unknown. In addition, it is unclear 
whether host cell death requires a 
single or multiple proteases. If they are 
multiple, then, how are their activities 
coordinated or are they acting 
independently of each other? These 
questions need to be addressed before 
we can begin to fully appreciate the 
complexity of the pathogenic 
mechanisms of Acanthamoeba 
infections. Recent studies have shown 
that human corneal epithelial cells 
express protease-activated receptors 
(PARs) (Lang et al., 2003). PARs are 
G-protein-coupled receptors that are 
expressed on various cell types and are 
known to mediate cellular responses to 
injury, inflammation, or infection (Vu 
et al., 1991). PARs are activated upon 
proteolytic cleavage of their N-
terminus by serine proteases. This 
cleavage exposes the ligand domain of 
the receptor that binds to and activate 
the cleaved receptor (Lang et al., 
2003). To date, four members of PARs 
family have been identified, PAR-1, 
PAR-2, PAR-3 and PAR-4. Among 
these, PAR-1 has been implicated as a 
key mediators in cellular functions and 
activated by PAR-1 agonists, thrombin 
as well as by serine proteases, and 
PAR-2 are activated by trypsin-like 
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serine proteases (Cirino et al., 1996; 
Grandaliano et al., 1994; Naldini et al., 
1993). Of interest, PAR-1, PAR-2 and 
PAR-3 are all expressed on human 
corneal epithelial cells (Lang et al., 
2003) suggesting that amoeba serine 
proteases may act in a receptor-
dependent fashion to produce host cell 
damage. Identification of the 
receptor(s) for amoeba proteases will 
lead to dissect the precise host 
intracellular signaling pathways, which 
results in cellular and tissue damage. 
Studies in the understanding of the role 
of proteases and their precise 
mechanisms will undoubtedly identify 
targets for therapeutic interventions. 
 
B)  Indirect virulence factors 
As indicated above, the ability of 
Acanthamoeba to produce human 
diseases is a multifactorial process and 
is dependent on its ability to survive 
outside its mammalian host for 
variable periods of time and under 
diverse environmental conditions, such 
as, high osmolarity and varying 
temperatures on the surface of cornea. 
In this section, I will describe the role 
of environmental as well as host 
factors, which may play key roles in 
determining the successful 
transmission of these pathogens to a 
susceptible host.    
 
1.  Morphology 
Infective forms of Acanthamoeba or 
trophozoites do not have a distinct 
morphology, however, they do possess 
spine like structures known as 
acanthopodia on their surface, which 
may play a key role in the pathogenesis 
of Acanthamoeba infections (Khan, 
2001). Previously, we have shown that 
binding of pathogenic Acanthamoeba 
to corneal epithelial cells is mediated 
by acanthopodia (Khan, 2001). We 
further showed that Acanthamoeba 
which lack acanthopodia (non-
pathogens) did not exhibit binding to 
corneal epithelial cells suggesting that 
these structures may work as a 
protraction to make initial contact with 
the host cells (Fig. 4). It will not be 
surprising to find that mannose-binding 
protein, which is involved in binding 
of amoebae with host cells is localized 
on acanthopodia, however, this has not 
been determined. Overall, these studies 
have suggested that acanthopodia 
represent a virulence trait (Fig. 4). 
However, more extensive studies are 
needed to fully establish the role of 
acanthopodia and other morphological 
traits in the pathogenesis of 
Acanthamoeba.  
 
 
Figure 4. Binding of Acanthamoeba to 
corneal epithelial cells is mediated by 
acanthopodia. Acanthamoeba castellanii 
were incubated with corneal epithelial 
cells, and observed under scanning 
electron microscope. Note that parasites 
were able to exhibit binding to the host 
cells and binding was mediated by 
acanthopodia. A is amoeba, E is corneal 
epithelial cell. Bar = 10 µm (reprinted with 
permission from Microbial Pathogenesis).  
 
2.  Temperature tolerance and 
osmotolerance 
Upon contact with tear film and 
corneal epithelial cells, Acanthamoeba 
are exposed to high osmolarity (for 
example salinity in tears) as well as 
high temperatures. For successful 
transmission, amoebae must withstand 
these burdens and exhibit growth. 
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Growth at high temperature and high 
osmolarity are known to be the 
hallmark of pathogenic Acanthamoeba 
(De Jonckheere, 1983; Ficker, 1988; 
Khan et al., 2001a; Khan et al., 2002; 
Walochnik et al., 2000a).  These 
studies have shown that the ability of 
Acanthamoeba to grow at high 
temperature and high osmolarity can 
be directly correlated with the 
pathogenicity of Acanthamoeba 
isolates. However, the precise 
mechanisms of pathogenic 
Acanthamoeba to adapt to higher 
temperatures and maintain metabolic 
activities remain entirely unknown. For 
example, temperature tolerance studies 
in Candida neoformans have identified 
Ca2+-dependent protein phosphatase 
calcineurin to be required for its 
growth at 37°C (Odom et al., 1997; 
Odom et al., 1997a). Furthermore these 
studies showed C. neoformans strains 
in which calcineurin gene has been 
disrupted are avirulent in an in vivo 
model of cryptococcal meningitis. 
These studies might serve as a basis 
and a stimulus for research in the 
pathogenesis of Acanthamoeba 
infections. Overall, these simple 
growth assays have been used as 
markers for the differentiation of 
pathogenic and non-pathogenic 
Acanthamoeba isolates. 
 
3.  Growth at different pH 
Pathogenic Acanthamoeba can grow 
both at acidic and basic pH, which 
suggests its ability to colonize several 
niches. Acanthamoeba are known to 
grow at pH ranging from 4 – 12 
(Ficker, 1988; Khan et al., unpublished 
data). However, the clinical 
significance of the ability of 
Acanthamoeba to exhibit growth at 
different pH is not known. For 
example, in Candida albicans, the 
ability to grow at diverse pH is crucial 
for its virulence (Davis et al., 2000). 
Further studies identified two pH-
regulated genes, PHR1 (expressed at 
neutral and basic pH) and PHR2 
(expressed at acid pH). Deletion of 
PHR2 resulted in loss of virulence and 
deletion of PHR1 resulted in reduced 
virulence in a systemic model (De 
Bernardis et al., 1998). Again, similar 
studies will form a basis and provide a 
model to determine whether growth of 
Acanthamoeba at different pH plays a 
role in the pathogenesis of 
Acanthamoeba infections. 
 
4.  Phenotypic switching 
Phenotypic switching is the ability of 
Acanthamoeba to differentiate into a 
morphologically distinct dormant cyst 
form or a vegetative trophozoite form. 
This is a reversible change and is 
dependent on environmental conditions 
(Fig. 1). Cysts are resistant to various 
antimicrobial agents and adverse 
conditions, thus, presenting a problem 
in chemotherapy because this may lead 
to recurrence of the disease. In 
addition, cysts can survive harsh 
environmental conditions, such as high 
temperatures and desiccation and they 
can be airborne (Byers, 1979; 
Cordingley et al., 1996; Turner et al., 
2000; Weisman, 1976). Furthermore, 
Acanthamoeba cysts can survive up to 
several years while maintaining their 
pathogenicity (Mazur et al., 1995). 
These characteristics suggest that the 
primary functions of cysts may lie in 
withstanding adverse conditions and in 
the spreading of amoebae throughout 
the environment. In addition, this may 
represent the ability of Acanthamoeba 
to alternate expression of surface 
proteins/glycoproteins, which may help 
evade immune surveillance in addition 
to changing environments. Most of 
these variations can be reversible and 
lead to the expression of predefined 
traits. At present it is not clear whether 
other mechanisms such as antigenic 
variation exists and their relevance in 
phenotypic switching. However, future 
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studies will address these issues. 
Overall, phenotypic switching 
represents a major factor in the 
transmission of Acanthamoeba 
infections, however, the underlying 
molecular mechanisms in these 
processes remain to be determined.  
 
5.  Drug resistance 
Current treatment for Acanthamoeba 
keratitis involves topical application of 
mixture of drugs including 
chlorhexidine, polyhexamethylene 
biguanide (PHMB), neomycin and 
propamidine isethionate. These drugs 
have been shown to be most effective 
in killing Acanthamoeba trophozoites 
(Cohen et al., 1987; Hay et al., 1994; 
Larkin et al., 1992; Lim et al., 2000; 
Lloyd et al., 2001; Moore and 
McCulley 1989; Murdoch et al., 1998; 
Russell and Chopra, 1996; Seal et al., 
1995; Turner et al., 2000; Wright et 
al., 1985). Both chlorhexidine 
diacetate and PHMB are “membrane-
acting” cationic biocides. At alkaline 
pH, surface proteins of Acanthamoeba 
are negatively charged interacting 
rapidly with these cationic biocides 
inducing structural and permeability 
changes in cell membrane leading to 
leakage of ions, water and other 
cytoplasmic components resulting in 
cellular damage (Perrine et al., 1995). 
Other drugs are propamidine 
isethionate belonging to diamidine 
family and are effective DNA 
synthesis inhibitor (Duguid et al., 
1997). Of concern, several studies have 
recently shown the increasing 
resistance of Acanthamoebae to 
antimicrobial chemotherapy, however, 
the mechanisms of drug resistance in 
Acanthamoeba remain incompletely 
understood (Ficker et al., 1990; Larkin 
et al., 1992; Lim et al., 2000; Lloyd et 
al., 2001; Murdoch et al., 1998). One 
intriguing report was made by Ficker et 
al., (1990), who observed the 
development of propamidine resistance 
during the course of therapy for 
Acanthamoeba keratitis, which lead to 
recurrence of the infection. This may 
be due to the fact that propamidine 
isethionate belong to diamidine family 
and are effective DNA synthesis 
inhibitor (Johnson & Thomas, 2002), 
but may not be potent against cyst 
forms of Acanthamoeba at 
recommended concentrations, due to 
their reproductive and metabolic 
inactivity. Also, Acanthamoeba cysts 
are double-walled consisting of an 
inner endocyst and an outer ectocyst 
(composed of 33% protein, 4 – 6% 
lipids and 35% carbohydrates, mostly 
cellulose), which may also provide a 
physical barrier against various 
chemotherapeutic agents (Neff & Neff, 
1969; Turner et al., 2000). Additional 
factors may involve selection under 
continuous drug pressure with genetic 
basis such as point mutations or 
transferable genes and/or variations in 
metabolic activities. Precise 
understanding of these mechanisms is 
crucial for the rationale development 
of much needed drugs for this serious 
disease.  
 
As described earlier, other infections 
due to Acanthamoeba are 
granulomatous amoebic encephalitis 
(GAE) that almost always proves fatal. 
However, there are no recommended 
treatments for GAE. This is due to low 
sensitivity of Acanthamoeba to many 
antiamoebic agents and the low level 
of ability of these agents to cross the 
blood-brain barrier into the central 
nervous system. Recent studies have 
indicated that alkylphosphocholine 
compounds, such as 
hexadecylphosphocholine, cross the 
blood-brain barrier and have in vitro 
antiamoebic activity (Walochnik et al., 
2002; Kotting et al., 1992). Further 
studies are needed to determine their 
precise mode of action on 
Acanthamoeba, methods of application 
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and more importantly, success of these 
agents in vivo studies. Overall these 
studies have indicated the obvious 
need to find alternative means for 
successful treatment of these 
potentially devastating infections. 
 
6.  Ubiquity 
As described in the introduction, 
Acanthamoebae are found in diverse 
environments, from drinking water to 
distilled water wash bottles. It is not 
surprising that we often come across 
and interact with these organisms. 
Previously Chappell et al., (2001), 
showed that > 80 % of the normal 
human population exhibited antibodies 
against Acanthamoeba. This clearly 
indicated that these are one of the most 
ubiquitous organisms and that they 
often come in contact with humans. 
 
7.  Biofilm formation 
Biofilms are known to play an 
important role in the pathogenesis of 
Acanthamoeba keratitis. Biofilms are 
microbially derived sessile 
communities, which can be formed in 
aqueous environments as well as on 
any materials and medical devices 
including intravenous catheters, 
contact lenses, scleral buckles, suture 
material, and intraocular lenses 
(Zegans et al., 2002). With reference to 
contact lenses, biofilms are formed 
through contamination of the storage 
case. Once established, biofilms 
provide attractive niches to 
Acanthamoeba, by fulfilling their 
nutritional requirements as well as 
providing resistance to disinfectants. In 
support, Beattie et al., (2003) have 
recently shown that Acanthamoeba 
exhibited significant higher binding to 
worn and Pseudomonas biofilm-coated 
hydrogel lenses as compared to 
unworn lenses clearly indicating that 
biofilms enhances Acanthamoeba 
adherence to contact lenses. In 
addition, abundance of nutrition 
provides means for the transformation 
of Acanthamoeba into the vegetative, 
infective trophozoite form. It is 
important to indicate that 
Acanthamoeba adherence to human 
corneal epithelial cells most likely 
occurs during the trophozoite stage as 
cysts exhibit no and/or minimal 
binding (unpublished data). Overall, 
these findings suggest that biofilms 
play an important role in 
Acanthamoeba keratitis in contact lens 
users and intervening this process will 
provide preventive strategies.       
 
8.  Host factors 
As described earlier, the ability of 
Acanthamoeba to cause infection is 
equally dependent on the host factors 
as it is on the parasite. However, the 
extent to which host factors contribute 
to the outcome of Acanthamoeba 
infections is unclear. This is due to the 
fact that host factors are more complex 
and difficult to study than those of the 
parasite. For example, in Salmonella 
infections, the genetic constitution of 
the host determines susceptibility to 
infection (Harrington and Hormaeche, 
1986). However, these studies were 
possible only due to the availability of 
transgenic animals. There are multiple 
host factors, which may contribute to 
Acanthamoeba infections. For 
example, >90% of Acanthamoeba 
keratitis is known to occur in people 
who wear contact lens. In comparison, 
granulomatous amebic encephalitis due 
to Acanthamoeba has been reported 
only in immunocompromised 
individuals. In addition, malnutrition, 
mental stress, age, metabolic factors, 
and other primary infections may play 
a role in the pathogenesis of 
Acanthamoeba infections.   
 
CONCLUSIONS 
Acanthamoeba pathogenicity is a sum 
of multiple processes, which must 
come together in time and space for the 
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successful transmission of the 
pathogens to a susceptible host, 
overcome host barriers and cause 
disease. One of the key factors in 
Acanthamoeba pathogenesis is its 
ability to adapt to diverse conditions, 
both under stress, by transformation 
into cysts and emerging as vegetative 
trophozoite form under favourable 
conditions. We are only beginning to 
appreciate the complex nature of these 
organisms and the associated 
mechanisms that are employed to 
produce human diseases. This has been 
made possible due to recent 
developments in the availability of 
both in vitro and in vivo models of 
Acanthamoeba keratitis. In particular, 
the use of corneal epithelial cells in 
vitro assays has and will continue to 
provide insights into the precise 
mechanisms of Acanthamoeba 
pathogenesis, which may provide tools 
for the successful development of 
therapeutic interventions. 
 
Studies to date have identified that 
binding of Acanthamoeba to host cells 
is mediated by mannose-binding 
protein that leads to secondary events 
such as phagocytosis, apoptosis and 
secretion of toxins such as extracellular 
proteases, which play a more direct 
role in host cellular and tissue damage. 
Extracellular proteases are considered 
both as necrotic as well as apoptotic 
agents and are major determinants in 
the pathogenesis of Acanthamoeba 
infections. However, Acanthamoeba 
are opportunistic organisms and it is 
likely that these enzymes may have 
evolved for nutritional purposes i.e., 
degradation of food particles and thus 
their major role in infection is host 
tissue degradation. Further 
investigations require understanding of 
their basic biochemical mechanisms, 
their relevance to each other, ability to 
cause disease and their interactions 
with host defense systems.   
 
In addition, future studies are needed 
to identify the genetic basis for these 
virulence factors to produce disease. 
To show the importance of these 
virulence factors, it is crucial to show 
simultaneous loss of the factor and loss 
of virulence and complementing this 
property with regain of the factor. 
These will require precise genetic 
manipulations of single or multiple 
virulence genes, which will further 
assess the contribution of these 
virulence factors in the pathogenesis of 
Acanthamoeba infections. Since both 
parasite and host factors seems to be 
equally important in the pathogenesis 
of Acanthamoeba infections, it is 
reasonable to predict that emerging 
genomics will have the potential to 
provide insights into these vision-
threatening and fatal infections. 
Further research in such areas will 
undoubtedly provide strategies to 
design novel therapeutic interventions.    
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